Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil for severe asthma
IRCT20200823048482N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in asthma comparing Tadalafil add-on with Placebo add-on (2 arms). Primary endpoints: Forced expiratory volume in 1 second, Forced vital capacity and 5 more. Started Oct 2020; status: completed.
02
Drugs
tadalafil
03
Conditions
asthma
Beyond the preview
Go deeper on IRCT20200823048482N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200823048482N1.